These include those loci traditionally noted as “Parkinson loci” as well as others that are not, including MAPT, SCA2, SCA3, and spastacsin, which can clinically present as Parkinson disease but often is clinically distinct. This evidence concerns the gene ATXN3 and Parkinson disease.